Contact this trialFirst, we need to learn more about you.
Mirikizumab Solution (Reference) for Healthy Subjects
Recruiting1 awardPhase 1
Dallas, Texas
This trial evaluates how well a drug is tolerated & how much gets into the bloodstream when given via syringe. Adverse effects & duration of 17 wks incl. 35 day screening are also evaluated.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.